These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6361850)

  • 21. Mechanisms of selective toxicity of metronidazole and other nitroimidazole drugs.
    Edwards DI
    Br J Vener Dis; 1980 Oct; 56(5):285-90. PubMed ID: 7000306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New drugs: Tiberal Roche].
    Hofstetter A
    Urologe A; 1977 Sep; 16(5):308-9. PubMed ID: 906196
    [No Abstract]   [Full Text] [Related]  

  • 23. Chemotherapeutically active nitro compounds. 4.5-Nitroimidazoles (Part II).
    Winkelmann E; Raether W; Sinharay A
    Arzneimittelforschung; 1978; 28(3):351-66. PubMed ID: 350230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alkylation of 2-methyl-5-nitroimidazole. Some potent antiprotozoal agents.
    Miller MW; Howes HL; Kasubick RV; English AR
    J Med Chem; 1970 Sep; 13(5):849-52. PubMed ID: 5458368
    [No Abstract]   [Full Text] [Related]  

  • 25. [Synthesis and antiparasitic activity of arylproprenones in the nitro-5-imidazole series].
    Ouattara L; Debaert M; Cavier R
    Farmaco Sci; 1988 Apr; 43(4):389-93. PubMed ID: 2904887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitroimidazoles: Molecular Fireworks That Combat a Broad Spectrum of Infectious Diseases.
    Ang CW; Jarrad AM; Cooper MA; Blaskovich MAT
    J Med Chem; 2017 Sep; 60(18):7636-7657. PubMed ID: 28463485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical trial of benznidazole and an immunopotentiator against Chagas disease in Chile.
    Apt W; Arribada A; Arab F; Ugarte JM; Luksic I; Solé C
    Trans R Soc Trop Med Hyg; 1986; 80(6):1010. PubMed ID: 3299901
    [No Abstract]   [Full Text] [Related]  

  • 28. Synthesis and biological properties of 1-methyl-2-[(4-aminophenyl)-sulfonyl-]amino-5-nitro imidazole.
    Bertolini A; Castelli M; Borella F; Dall' Asta L; Comini A; Alberti D; Coppi G
    Boll Chim Farm; 1989 Feb; 128(2):71-3. PubMed ID: 2775520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Synthesis and antiparasitic activity of new nitro-5-imidazole derivatives].
    Quattara L; Debaert M; Cavier R
    Farmaco Sci; 1987 Jun; 42(6):449-56. PubMed ID: 2888689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nitroimidazole drugs--action and resistance mechanisms. II. Mechanisms of resistance.
    Edwards DI
    J Antimicrob Chemother; 1993 Feb; 31(2):201-10. PubMed ID: 8463167
    [No Abstract]   [Full Text] [Related]  

  • 31. Nitroimidazoles as anaerobic electron acceptors for xanthine oxidase.
    Clarke ED; Goulding KH; Wardman P
    Biochem Pharmacol; 1982 Oct; 31(20):3237-42. PubMed ID: 6897358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacology and toxicology of sensitizers: mechanism studies.
    Rauth AM
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1293-300. PubMed ID: 6469753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1-Aryl-4-nitro-1H-imidazoles, a new promising series for the treatment of human African trypanosomiasis.
    Trunz BB; Jędrysiak R; Tweats D; Brun R; Kaiser M; Suwiński J; Torreele E
    Eur J Med Chem; 2011 May; 46(5):1524-35. PubMed ID: 21353728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tinidazole for prophylaxis in gynaecological surgery.
    Pavillard ER
    J Antimicrob Chemother; 1982 Aug; 10 Suppl A():79-80. PubMed ID: 7118777
    [No Abstract]   [Full Text] [Related]  

  • 35. Anti-Trichomonas effect of azomycin.
    HORIE H
    J Antibiot (Tokyo); 1956 Jul; 9(4):168. PubMed ID: 13385191
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypoxia-selective antitumor agents. 10. bis(nitroimidazoles) and related Bis(nitroheterocycles): development of derivatives with higher rates of metabolic activation under hypoxia and improved aqueous solubility.
    Hay MP; Lee HH; Wilson WR; Roberts PB; Denny WA
    J Med Chem; 1995 May; 38(11):1928-41. PubMed ID: 7783125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitroimidazoles with antibacterial activity against Neisseria gonorrhoeae.
    Tweit RC; Muir RD; Ziecina S
    J Med Chem; 1977 Dec; 20(12):1697-700. PubMed ID: 412966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On a new class of mixed-function drugs associating nitroimidazoles and CENU: the NICE-NU.
    Carminati A; Barascut JL; Chenut E; Bourut C; Mathé G; Imbach JL
    Anticancer Drug Des; 1988 Jun; 3(1):57-65. PubMed ID: 3382507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chemotherapeutically effective nitro compounds. 3rd communication: nitropyridines, nitroimidazopyridines and related compounds (author's transl)].
    Winkelmann E; Raether W; Hartung H; Wagner WH
    Arzneimittelforschung; 1977; 27(1):82-9. PubMed ID: 576820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of partitioning of nitroimidazoles in the n-octanol/saline and liposome systems with pharmacokinetic parameters and quantitative structure-activity relationships (QSAR).
    Betageri GV; Rogers JA
    Pharm Res; 1989 May; 6(5):399-403. PubMed ID: 2748530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.